“Inclisiran first” strategy yields greater LDL-C reduction in ASCVD patients

Among patients with atherosclerotic cardiovascular disease (ASCVD) who fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals despite receiving maximally tolerated statins, initiating inclisiran immediately resulted in significant reductions in LDL-C, according to the VICTORION-INITIATE trial presented at ACC.24.

Psychosocial risks may impair child’s development
Adverse childhood experiences (ACEs), financial needs, and other maternal psychosocial hardships can negatively affect the development of children from vulnerable families in Singapore, according to a study.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in